nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—PLA2G4A—asthma	0.42	1	CbGaD
Epirubicin—PLA2G4A—Fluticasone Propionate—asthma	0.276	1	CbGbCtD
Epirubicin—CHD1—respiratory system—asthma	0.00295	0.0616	CbGeAlD
Epirubicin—CHD1—adrenal cortex—asthma	0.00248	0.0517	CbGeAlD
Epirubicin—CHD1—bronchus—asthma	0.00243	0.0507	CbGeAlD
Epirubicin—CHD1—trachea—asthma	0.00218	0.0455	CbGeAlD
Epirubicin—YWHAG—respiratory system—asthma	0.00182	0.0381	CbGeAlD
Epirubicin—CHD1—adrenal gland—asthma	0.00179	0.0373	CbGeAlD
Epirubicin—DHCR7—adrenal cortex—asthma	0.00167	0.0349	CbGeAlD
Epirubicin—DHCR7—bronchus—asthma	0.00164	0.0342	CbGeAlD
Epirubicin—CHD1—lung—asthma	0.00157	0.0327	CbGeAlD
Epirubicin—YWHAG—adrenal cortex—asthma	0.00153	0.032	CbGeAlD
Epirubicin—YWHAG—bronchus—asthma	0.0015	0.0314	CbGeAlD
Epirubicin—DHCR7—trachea—asthma	0.00147	0.0307	CbGeAlD
Epirubicin—YWHAG—smooth muscle tissue—asthma	0.00147	0.0307	CbGeAlD
Epirubicin—AURKA—adrenal gland—asthma	0.00144	0.0301	CbGeAlD
Epirubicin—YWHAG—cardiovascular system—asthma	0.0014	0.0292	CbGeAlD
Epirubicin—PLA2G4A—respiratory system—asthma	0.00136	0.0284	CbGeAlD
Epirubicin—YWHAG—trachea—asthma	0.00135	0.0282	CbGeAlD
Epirubicin—AURKA—lung—asthma	0.00126	0.0264	CbGeAlD
Epirubicin—DHCR7—adrenal gland—asthma	0.0012	0.0252	CbGeAlD
Epirubicin—Doxorubicin—NOS1—asthma	0.00116	0.369	CrCbGaD
Epirubicin—PLA2G4A—adrenal cortex—asthma	0.00114	0.0239	CbGeAlD
Epirubicin—PLA2G4A—bronchus—asthma	0.00112	0.0234	CbGeAlD
Epirubicin—YWHAG—adrenal gland—asthma	0.00111	0.0231	CbGeAlD
Epirubicin—PLA2G4A—smooth muscle tissue—asthma	0.0011	0.0229	CbGeAlD
Epirubicin—TOP2A—bronchus—asthma	0.00106	0.0222	CbGeAlD
Epirubicin—DHCR7—lung—asthma	0.00106	0.0221	CbGeAlD
Epirubicin—PLA2G4A—cardiovascular system—asthma	0.00104	0.0218	CbGeAlD
Epirubicin—PLA2G4A—trachea—asthma	0.00101	0.021	CbGeAlD
Epirubicin—YWHAG—lung—asthma	0.000969	0.0202	CbGeAlD
Epirubicin—PLA2G4A—adrenal gland—asthma	0.000825	0.0172	CbGeAlD
Epirubicin—TOP2A—adrenal gland—asthma	0.000783	0.0164	CbGeAlD
Epirubicin—Doxorubicin—NQO1—asthma	0.000745	0.237	CrCbGaD
Epirubicin—PLA2G4A—lung—asthma	0.000723	0.0151	CbGeAlD
Epirubicin—TOP2A—lung—asthma	0.000687	0.0143	CbGeAlD
Epirubicin—ABCC1—adrenal cortex—asthma	0.000653	0.0136	CbGeAlD
Epirubicin—PLA2G4A—Glyburide—Zafirlukast—asthma	0.000647	0.201	CbGdCrCtD
Epirubicin—ABCC1—bronchus—asthma	0.000641	0.0134	CbGeAlD
Epirubicin—Doxorubicin—NOS3—asthma	0.000629	0.2	CrCbGaD
Epirubicin—Doxorubicin—NOS2—asthma	0.000607	0.194	CrCbGaD
Epirubicin—ABCC1—trachea—asthma	0.000575	0.012	CbGeAlD
Epirubicin—TOP2A—Procaterol—Indacaterol—asthma	0.000571	0.177	CbGdCrCtD
Epirubicin—ABCC1—adrenal gland—asthma	0.000472	0.00985	CbGeAlD
Epirubicin—ABCC1—lung—asthma	0.000413	0.00864	CbGeAlD
Epirubicin—TOP2A—Procaterol—Isoetarine—asthma	0.000219	0.0678	CbGdCrCtD
Epirubicin—TOP2A—Salmeterol—Salbutamol—asthma	0.000182	0.0563	CbGdCrCtD
Epirubicin—PLA2G4A—Pindolol—Isoprenaline—asthma	0.000179	0.0554	CbGdCrCtD
Epirubicin—TOP2A—Methyldopa—Isoetarine—asthma	9.46e-05	0.0293	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Fluticasone furoate—asthma	9.25e-05	0.0286	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Fluticasone furoate—asthma	9.25e-05	0.0286	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Fluticasone Propionate—asthma	8.63e-05	0.0267	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Fluticasone Propionate—asthma	8.63e-05	0.0267	CbGdCrCtD
Epirubicin—TOP2A—Methyldopa—Isoprenaline—asthma	7.17e-05	0.0222	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Beclomethasone—asthma	6.34e-05	0.0196	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Beclomethasone—asthma	6.34e-05	0.0196	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Budesonide—asthma	6.08e-05	0.0188	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Budesonide—asthma	6.08e-05	0.0188	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Flunisolide—asthma	6e-05	0.0186	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Flunisolide—asthma	6e-05	0.0186	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Mometasone—asthma	4.92e-05	0.0152	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Mometasone—asthma	4.92e-05	0.0152	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Hydrocortisone—asthma	3.11e-05	0.00964	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Hydrocortisone—asthma	3.11e-05	0.00964	CbGdCrCtD
Epirubicin—PLA2G4A—Metabolism—ALDH7A1—asthma	3.02e-05	0.000503	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2RB—asthma	2.99e-05	0.000498	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—asthma	2.99e-05	0.000498	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ITPR1—asthma	2.99e-05	0.000497	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL22—asthma	2.97e-05	0.000495	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTGDR—asthma	2.97e-05	0.000495	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LTB4R—asthma	2.97e-05	0.000495	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PDE4D—asthma	2.97e-05	0.000493	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ARG2—asthma	2.96e-05	0.000492	CbGpPWpGaD
Epirubicin—PLA2G4A—Betamethasone—Methylprednisolone—asthma	2.94e-05	0.00909	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Methylprednisolone—asthma	2.94e-05	0.00909	CbGdCrCtD
Epirubicin—PLA2G4A—Metabolism—ARG2—asthma	2.9e-05	0.000482	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—C5—asthma	2.89e-05	0.000481	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PDE4B—asthma	2.89e-05	0.000481	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—TACR1—asthma	2.89e-05	0.000481	CbGpPWpGaD
Epirubicin—PLA2G4A—Dexamethasone—Betamethasone—asthma	2.89e-05	0.00895	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Dexamethasone—asthma	2.89e-05	0.00895	CbGdCrCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	2.86e-05	0.000476	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDK2—asthma	2.84e-05	0.000472	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IL2—asthma	2.83e-05	0.000471	CbGpPWpGaD
Epirubicin—PLA2G4A—Dexamethasone—Triamcinolone—asthma	2.82e-05	0.00874	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Triamcinolone—asthma	2.82e-05	0.00874	CbGdCrCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—asthma	2.81e-05	0.000467	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—PPP2CA—asthma	2.8e-05	0.000466	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—CSF2—asthma	2.76e-05	0.000459	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	2.7e-05	0.00045	CbGpPWpGaD
Epirubicin—PLA2G4A—Betamethasone—Prednisone—asthma	2.68e-05	0.0083	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Prednisone—asthma	2.68e-05	0.0083	CbGdCrCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—asthma	2.67e-05	0.000445	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ARG1—asthma	2.67e-05	0.000444	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCR3—asthma	2.64e-05	0.00044	CbGpPWpGaD
Epirubicin—PLA2G4A—Betamethasone—Prednisolone—asthma	2.62e-05	0.0081	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Prednisolone—asthma	2.62e-05	0.0081	CbGdCrCtD
Epirubicin—PLA2G4A—Signaling by GPCR—NPY—asthma	2.58e-05	0.000429	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PPP2CA—asthma	2.57e-05	0.000428	CbGpPWpGaD
Epirubicin—TOP2A—Methyltestosterone—Hydrocortisone—asthma	2.55e-05	0.0079	CbGdCrCtD
Epirubicin—TOP2A—Cell Cycle—CDK2—asthma	2.54e-05	0.000422	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PMCH—asthma	2.53e-05	0.000421	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NPSR1—asthma	2.53e-05	0.000421	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTGDR2—asthma	2.53e-05	0.000421	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HRH4—asthma	2.53e-05	0.000421	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IL2RA—asthma	2.49e-05	0.000414	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AGTR2—asthma	2.49e-05	0.000414	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	2.48e-05	0.000413	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CSF2RB—asthma	2.47e-05	0.000412	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ADCY2—asthma	2.47e-05	0.00041	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALOX15—asthma	2.45e-05	0.000407	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALOX5AP—asthma	2.45e-05	0.000407	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—asthma	2.43e-05	0.000405	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TACR2—asthma	2.42e-05	0.000403	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR8—asthma	2.42e-05	0.000403	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALDH7A1—asthma	2.42e-05	0.000402	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—asthma	2.41e-05	0.0004	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALOX5AP—asthma	2.4e-05	0.0004	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALOX15—asthma	2.4e-05	0.0004	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PDGFB—asthma	2.4e-05	0.000399	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EDNRB—asthma	2.38e-05	0.000396	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL17—asthma	2.38e-05	0.000395	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—POMC—asthma	2.36e-05	0.000393	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—TAC1—asthma	2.36e-05	0.000392	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—NPS—asthma	2.36e-05	0.000392	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CHAT—asthma	2.34e-05	0.000389	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—CDK2—asthma	2.33e-05	0.000388	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PLAU—asthma	2.33e-05	0.000388	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ARG2—asthma	2.32e-05	0.000385	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—asthma	2.32e-05	0.000385	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCR3—asthma	2.31e-05	0.000384	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CHAT—asthma	2.29e-05	0.000381	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—asthma	2.21e-05	0.000367	CbGpPWpGaD
Epirubicin—TOP2A—Methyltestosterone—Prednisone—asthma	2.2e-05	0.0068	CbGdCrCtD
Epirubicin—PLA2G4A—Signaling by GPCR—IL5—asthma	2.19e-05	0.000364	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—FN1—asthma	2.17e-05	0.00036	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ALB—asthma	2.16e-05	0.000358	CbGpPWpGaD
Epirubicin—TOP2A—Methyltestosterone—Prednisolone—asthma	2.14e-05	0.00664	CbGdCrCtD
Epirubicin—PLA2G4A—Hemostasis—NOS2—asthma	2.14e-05	0.000356	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KIF3A—asthma	2.12e-05	0.000352	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PDE4A—asthma	2.12e-05	0.000352	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—BDKRB2—asthma	2.11e-05	0.000352	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALOX5—asthma	2.08e-05	0.000346	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—HMOX1—asthma	2.07e-05	0.000345	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—IL6—asthma	2.07e-05	0.000345	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—NOS3—asthma	2.06e-05	0.000343	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—ADCY2—asthma	2.05e-05	0.00034	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALOX5—asthma	2.04e-05	0.00034	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL3—asthma	2.04e-05	0.000339	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	2.03e-05	0.000338	CbGpPWpGaD
Epirubicin—Oedema—Hydrocortisone—asthma	2.03e-05	0.000107	CcSEcCtD
Epirubicin—Anaphylactic shock—Hydrocortisone—asthma	2.03e-05	0.000107	CcSEcCtD
Epirubicin—Convulsion—Triamcinolone—asthma	2.03e-05	0.000107	CcSEcCtD
Epirubicin—Tachycardia—Prednisolone—asthma	2.03e-05	0.000107	CcSEcCtD
Epirubicin—Convulsion—Methylprednisolone—asthma	2.02e-05	0.000107	CcSEcCtD
Epirubicin—Hypertension—Triamcinolone—asthma	2.02e-05	0.000107	CcSEcCtD
Epirubicin—Hypertension—Methylprednisolone—asthma	2.02e-05	0.000106	CcSEcCtD
Epirubicin—Infection—Hydrocortisone—asthma	2.02e-05	0.000106	CcSEcCtD
Epirubicin—Hyperhidrosis—Prednisolone—asthma	2.01e-05	0.000106	CcSEcCtD
Epirubicin—Shock—Hydrocortisone—asthma	2e-05	0.000105	CcSEcCtD
Epirubicin—Myalgia—Triamcinolone—asthma	1.99e-05	0.000105	CcSEcCtD
Epirubicin—Nervous system disorder—Hydrocortisone—asthma	1.99e-05	0.000105	CcSEcCtD
Epirubicin—Myalgia—Methylprednisolone—asthma	1.99e-05	0.000105	CcSEcCtD
Epirubicin—Arthralgia—Methylprednisolone—asthma	1.99e-05	0.000105	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—CARM1—asthma	1.99e-05	0.00033	CbGpPWpGaD
Epirubicin—Eye disorder—Prednisone—asthma	1.99e-05	0.000105	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CYSLTR1—asthma	1.98e-05	0.00033	CbGpPWpGaD
Epirubicin—Anxiety—Methylprednisolone—asthma	1.98e-05	0.000105	CcSEcCtD
Epirubicin—Tachycardia—Hydrocortisone—asthma	1.98e-05	0.000105	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	1.98e-05	0.000104	CcSEcCtD
Epirubicin—Flushing—Prednisone—asthma	1.97e-05	0.000104	CcSEcCtD
Epirubicin—Skin disorder—Hydrocortisone—asthma	1.97e-05	0.000104	CcSEcCtD
Epirubicin—Ill-defined disorder—Betamethasone—asthma	1.97e-05	0.000104	CcSEcCtD
Epirubicin—Ill-defined disorder—Dexamethasone—asthma	1.97e-05	0.000104	CcSEcCtD
Epirubicin—Discomfort—Triamcinolone—asthma	1.97e-05	0.000104	CcSEcCtD
Epirubicin—Discomfort—Methylprednisolone—asthma	1.97e-05	0.000104	CcSEcCtD
Epirubicin—Hyperhidrosis—Hydrocortisone—asthma	1.96e-05	0.000104	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—DCN—asthma	1.96e-05	0.000326	CbGpPWpGaD
Epirubicin—Dry mouth—Triamcinolone—asthma	1.95e-05	0.000103	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—CARM1—asthma	1.95e-05	0.000324	CbGpPWpGaD
Epirubicin—Anorexia—Hydrocortisone—asthma	1.93e-05	0.000102	CcSEcCtD
Epirubicin—Angiopathy—Prednisone—asthma	1.93e-05	0.000102	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—KNG1—asthma	1.92e-05	0.00032	CbGpPWpGaD
Epirubicin—Confusional state—Methylprednisolone—asthma	1.92e-05	0.000101	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—DCN—asthma	1.92e-05	0.000319	CbGpPWpGaD
Epirubicin—Immune system disorder—Prednisone—asthma	1.92e-05	0.000101	CcSEcCtD
Epirubicin—ABCC1—Metabolism—ALOX5AP—asthma	1.92e-05	0.000319	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALOX15—asthma	1.92e-05	0.000319	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—C5AR1—asthma	1.92e-05	0.000319	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL11—asthma	1.92e-05	0.000319	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CMA1—asthma	1.92e-05	0.000319	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—UTS2—asthma	1.92e-05	0.000319	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VIP—asthma	1.92e-05	0.000319	CbGpPWpGaD
Epirubicin—Malaise—Dexamethasone—asthma	1.92e-05	0.000101	CcSEcCtD
Epirubicin—Malaise—Betamethasone—asthma	1.92e-05	0.000101	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—AGTR1—asthma	1.91e-05	0.000318	CbGpPWpGaD
Epirubicin—Oedema—Triamcinolone—asthma	1.91e-05	0.000101	CcSEcCtD
Epirubicin—Anaphylactic shock—Triamcinolone—asthma	1.91e-05	0.000101	CcSEcCtD
Epirubicin—Vertigo—Dexamethasone—asthma	1.91e-05	0.000101	CcSEcCtD
Epirubicin—Vertigo—Betamethasone—asthma	1.91e-05	0.000101	CcSEcCtD
Epirubicin—Anaphylactic shock—Methylprednisolone—asthma	1.91e-05	0.000101	CcSEcCtD
Epirubicin—Syncope—Dexamethasone—asthma	1.91e-05	0.000101	CcSEcCtD
Epirubicin—Syncope—Betamethasone—asthma	1.91e-05	0.000101	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—ALDH2—asthma	1.91e-05	0.000317	CbGpPWpGaD
Epirubicin—Arrhythmia—Prednisone—asthma	1.9e-05	0.0001	CcSEcCtD
Epirubicin—Infection—Triamcinolone—asthma	1.9e-05	0.0001	CcSEcCtD
Epirubicin—Hypotension—Hydrocortisone—asthma	1.9e-05	0.0001	CcSEcCtD
Epirubicin—Infection—Methylprednisolone—asthma	1.89e-05	0.0001	CcSEcCtD
Epirubicin—DHCR7—Metabolism—PTGS2—asthma	1.89e-05	0.000314	CbGpPWpGaD
Epirubicin—Shock—Triamcinolone—asthma	1.88e-05	9.92e-05	CcSEcCtD
Epirubicin—Insomnia—Prednisolone—asthma	1.88e-05	9.92e-05	CcSEcCtD
Epirubicin—Alopecia—Prednisone—asthma	1.88e-05	9.91e-05	CcSEcCtD
Epirubicin—Shock—Methylprednisolone—asthma	1.88e-05	9.9e-05	CcSEcCtD
Epirubicin—Nervous system disorder—Methylprednisolone—asthma	1.87e-05	9.87e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL10—asthma	1.87e-05	0.000311	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALDH2—asthma	1.87e-05	0.000311	CbGpPWpGaD
Epirubicin—Loss of consciousness—Betamethasone—asthma	1.87e-05	9.86e-05	CcSEcCtD
Epirubicin—Loss of consciousness—Dexamethasone—asthma	1.87e-05	9.86e-05	CcSEcCtD
Epirubicin—Paraesthesia—Prednisolone—asthma	1.87e-05	9.85e-05	CcSEcCtD
Epirubicin—Tachycardia—Triamcinolone—asthma	1.87e-05	9.84e-05	CcSEcCtD
Epirubicin—Mental disorder—Prednisone—asthma	1.86e-05	9.83e-05	CcSEcCtD
Epirubicin—Tachycardia—Methylprednisolone—asthma	1.86e-05	9.82e-05	CcSEcCtD
Epirubicin—Skin disorder—Methylprednisolone—asthma	1.85e-05	9.77e-05	CcSEcCtD
Epirubicin—Malnutrition—Prednisone—asthma	1.85e-05	9.76e-05	CcSEcCtD
Epirubicin—Erythema—Prednisone—asthma	1.85e-05	9.76e-05	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Hydrocortisone—asthma	1.85e-05	9.76e-05	CcSEcCtD
Epirubicin—Hyperhidrosis—Triamcinolone—asthma	1.85e-05	9.75e-05	CcSEcCtD
Epirubicin—Hyperhidrosis—Methylprednisolone—asthma	1.84e-05	9.73e-05	CcSEcCtD
Epirubicin—Convulsion—Betamethasone—asthma	1.84e-05	9.72e-05	CcSEcCtD
Epirubicin—Convulsion—Dexamethasone—asthma	1.84e-05	9.72e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CCR4—asthma	1.84e-05	0.000306	CbGpPWpGaD
Epirubicin—Insomnia—Hydrocortisone—asthma	1.84e-05	9.69e-05	CcSEcCtD
Epirubicin—Hypertension—Betamethasone—asthma	1.83e-05	9.68e-05	CcSEcCtD
Epirubicin—Hypertension—Dexamethasone—asthma	1.83e-05	9.68e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—DCN—asthma	1.83e-05	0.000305	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CHAT—asthma	1.83e-05	0.000305	CbGpPWpGaD
Epirubicin—Paraesthesia—Hydrocortisone—asthma	1.82e-05	9.62e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—ADRB2—asthma	1.81e-05	0.000302	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTT1—asthma	1.81e-05	0.000301	CbGpPWpGaD
Epirubicin—Myalgia—Betamethasone—asthma	1.81e-05	9.55e-05	CcSEcCtD
Epirubicin—Myalgia—Dexamethasone—asthma	1.81e-05	9.55e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—SERPINE1—asthma	1.8e-05	0.0003	CbGpPWpGaD
Epirubicin—Anxiety—Betamethasone—asthma	1.8e-05	9.51e-05	CcSEcCtD
Epirubicin—Anxiety—Dexamethasone—asthma	1.8e-05	9.51e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—STAT6—asthma	1.8e-05	0.0003	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ALB—asthma	1.8e-05	0.000299	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—asthma	1.8e-05	0.000299	CbGpPWpGaD
Epirubicin—Discomfort—Betamethasone—asthma	1.79e-05	9.43e-05	CcSEcCtD
Epirubicin—Discomfort—Dexamethasone—asthma	1.79e-05	9.43e-05	CcSEcCtD
Epirubicin—Dyspepsia—Hydrocortisone—asthma	1.79e-05	9.43e-05	CcSEcCtD
Epirubicin—Hypotension—Methylprednisolone—asthma	1.78e-05	9.4e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—GSTT1—asthma	1.78e-05	0.000296	CbGpPWpGaD
Epirubicin—Pain—Prednisolone—asthma	1.78e-05	9.38e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—IL2RB—asthma	1.77e-05	0.000294	CbGpPWpGaD
Epirubicin—Decreased appetite—Hydrocortisone—asthma	1.76e-05	9.31e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—PDE4D—asthma	1.75e-05	0.000292	CbGpPWpGaD
Epirubicin—Gastrointestinal disorder—Hydrocortisone—asthma	1.75e-05	9.25e-05	CcSEcCtD
Epirubicin—Fatigue—Hydrocortisone—asthma	1.75e-05	9.23e-05	CcSEcCtD
Epirubicin—Vision blurred—Prednisone—asthma	1.74e-05	9.2e-05	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Triamcinolone—asthma	1.74e-05	9.19e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—RHOA—asthma	1.74e-05	0.000289	CbGpPWpGaD
Epirubicin—Musculoskeletal discomfort—Methylprednisolone—asthma	1.74e-05	9.17e-05	CcSEcCtD
Epirubicin—Pain—Hydrocortisone—asthma	1.74e-05	9.16e-05	CcSEcCtD
Epirubicin—Oedema—Betamethasone—asthma	1.73e-05	9.15e-05	CcSEcCtD
Epirubicin—Anaphylactic shock—Dexamethasone—asthma	1.73e-05	9.15e-05	CcSEcCtD
Epirubicin—Anaphylactic shock—Betamethasone—asthma	1.73e-05	9.15e-05	CcSEcCtD
Epirubicin—Oedema—Dexamethasone—asthma	1.73e-05	9.15e-05	CcSEcCtD
Epirubicin—Insomnia—Triamcinolone—asthma	1.73e-05	9.12e-05	CcSEcCtD
Epirubicin—Insomnia—Methylprednisolone—asthma	1.72e-05	9.1e-05	CcSEcCtD
Epirubicin—Infection—Dexamethasone—asthma	1.72e-05	9.09e-05	CcSEcCtD
Epirubicin—Infection—Betamethasone—asthma	1.72e-05	9.09e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—NOS3—asthma	1.72e-05	0.000286	CbGpPWpGaD
Epirubicin—Ill-defined disorder—Prednisone—asthma	1.72e-05	9.06e-05	CcSEcCtD
Epirubicin—Paraesthesia—Triamcinolone—asthma	1.72e-05	9.06e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—ITPR1—asthma	1.72e-05	0.000285	CbGpPWpGaD
Epirubicin—Feeling abnormal—Prednisolone—asthma	1.71e-05	9.04e-05	CcSEcCtD
Epirubicin—Paraesthesia—Methylprednisolone—asthma	1.71e-05	9.04e-05	CcSEcCtD
Epirubicin—Anaemia—Prednisone—asthma	1.71e-05	9.03e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—C5—asthma	1.71e-05	0.000284	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PDE4B—asthma	1.71e-05	0.000284	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TACR1—asthma	1.71e-05	0.000284	CbGpPWpGaD
Epirubicin—Shock—Dexamethasone—asthma	1.71e-05	9e-05	CcSEcCtD
Epirubicin—Shock—Betamethasone—asthma	1.71e-05	9e-05	CcSEcCtD
Epirubicin—Dyspnoea—Triamcinolone—asthma	1.7e-05	8.99e-05	CcSEcCtD
Epirubicin—Nervous system disorder—Betamethasone—asthma	1.7e-05	8.97e-05	CcSEcCtD
Epirubicin—Nervous system disorder—Dexamethasone—asthma	1.7e-05	8.97e-05	CcSEcCtD
Epirubicin—Agitation—Prednisone—asthma	1.7e-05	8.97e-05	CcSEcCtD
Epirubicin—Thrombocytopenia—Betamethasone—asthma	1.7e-05	8.96e-05	CcSEcCtD
Epirubicin—Thrombocytopenia—Dexamethasone—asthma	1.7e-05	8.96e-05	CcSEcCtD
Epirubicin—Tachycardia—Dexamethasone—asthma	1.69e-05	8.93e-05	CcSEcCtD
Epirubicin—Tachycardia—Betamethasone—asthma	1.69e-05	8.93e-05	CcSEcCtD
Epirubicin—Dyspepsia—Triamcinolone—asthma	1.68e-05	8.88e-05	CcSEcCtD
Epirubicin—Dyspepsia—Methylprednisolone—asthma	1.68e-05	8.86e-05	CcSEcCtD
Epirubicin—Hyperhidrosis—Betamethasone—asthma	1.68e-05	8.85e-05	CcSEcCtD
Epirubicin—Hyperhidrosis—Dexamethasone—asthma	1.68e-05	8.85e-05	CcSEcCtD
Epirubicin—Feeling abnormal—Hydrocortisone—asthma	1.67e-05	8.83e-05	CcSEcCtD
Epirubicin—Malaise—Prednisone—asthma	1.67e-05	8.81e-05	CcSEcCtD
Epirubicin—Vertigo—Prednisone—asthma	1.66e-05	8.77e-05	CcSEcCtD
Epirubicin—TOP2A—Norethindrone—Hydrocortisone—asthma	1.66e-05	0.00515	CbGdCrCtD
Epirubicin—Gastrointestinal pain—Hydrocortisone—asthma	1.66e-05	8.76e-05	CcSEcCtD
Epirubicin—Syncope—Prednisone—asthma	1.66e-05	8.76e-05	CcSEcCtD
Epirubicin—Anorexia—Betamethasone—asthma	1.65e-05	8.72e-05	CcSEcCtD
Epirubicin—Anorexia—Dexamethasone—asthma	1.65e-05	8.72e-05	CcSEcCtD
Epirubicin—Urticaria—Prednisolone—asthma	1.65e-05	8.71e-05	CcSEcCtD
Epirubicin—Fatigue—Triamcinolone—asthma	1.65e-05	8.7e-05	CcSEcCtD
Epirubicin—DHCR7—Metabolism—PTEN—asthma	1.64e-05	0.000273	CbGpPWpGaD
Epirubicin—Fatigue—Methylprednisolone—asthma	1.64e-05	8.68e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—asthma	1.64e-05	0.000272	CbGpPWpGaD
Epirubicin—Pain—Triamcinolone—asthma	1.63e-05	8.62e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—ALOX5—asthma	1.63e-05	0.000271	CbGpPWpGaD
Epirubicin—Loss of consciousness—Prednisone—asthma	1.63e-05	8.58e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—EDN1—asthma	1.62e-05	0.00027	CbGpPWpGaD
Epirubicin—Hypotension—Dexamethasone—asthma	1.62e-05	8.55e-05	CcSEcCtD
Epirubicin—Hypotension—Betamethasone—asthma	1.62e-05	8.55e-05	CcSEcCtD
Epirubicin—Urticaria—Hydrocortisone—asthma	1.61e-05	8.51e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL5—asthma	1.61e-05	0.000268	CbGpPWpGaD
Epirubicin—Body temperature increased—Hydrocortisone—asthma	1.6e-05	8.47e-05	CcSEcCtD
Epirubicin—Abdominal pain—Hydrocortisone—asthma	1.6e-05	8.47e-05	CcSEcCtD
Epirubicin—Convulsion—Prednisone—asthma	1.6e-05	8.46e-05	CcSEcCtD
Epirubicin—Hypertension—Prednisone—asthma	1.6e-05	8.43e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CSF2—asthma	1.58e-05	0.000263	CbGpPWpGaD
Epirubicin—Musculoskeletal discomfort—Betamethasone—asthma	1.58e-05	8.34e-05	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Dexamethasone—asthma	1.58e-05	8.34e-05	CcSEcCtD
Epirubicin—Arthralgia—Prednisone—asthma	1.58e-05	8.31e-05	CcSEcCtD
Epirubicin—Myalgia—Prednisone—asthma	1.58e-05	8.31e-05	CcSEcCtD
Epirubicin—Feeling abnormal—Triamcinolone—asthma	1.57e-05	8.31e-05	CcSEcCtD
Epirubicin—Feeling abnormal—Methylprednisolone—asthma	1.57e-05	8.29e-05	CcSEcCtD
Epirubicin—Anxiety—Prednisone—asthma	1.57e-05	8.28e-05	CcSEcCtD
Epirubicin—Insomnia—Dexamethasone—asthma	1.57e-05	8.28e-05	CcSEcCtD
Epirubicin—Insomnia—Betamethasone—asthma	1.57e-05	8.28e-05	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	1.56e-05	8.26e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CCR3—asthma	1.56e-05	0.00026	CbGpPWpGaD
Epirubicin—Gastrointestinal pain—Methylprednisolone—asthma	1.56e-05	8.23e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—CARM1—asthma	1.56e-05	0.000259	CbGpPWpGaD
Epirubicin—Paraesthesia—Dexamethasone—asthma	1.56e-05	8.22e-05	CcSEcCtD
Epirubicin—Paraesthesia—Betamethasone—asthma	1.56e-05	8.22e-05	CcSEcCtD
Epirubicin—Discomfort—Prednisone—asthma	1.56e-05	8.21e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—DCN—asthma	1.53e-05	0.000255	CbGpPWpGaD
Epirubicin—Hypersensitivity—Prednisolone—asthma	1.53e-05	8.08e-05	CcSEcCtD
Epirubicin—Dyspepsia—Dexamethasone—asthma	1.53e-05	8.06e-05	CcSEcCtD
Epirubicin—Dyspepsia—Betamethasone—asthma	1.53e-05	8.06e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—NPY—asthma	1.52e-05	0.000253	CbGpPWpGaD
Epirubicin—Urticaria—Triamcinolone—asthma	1.52e-05	8.01e-05	CcSEcCtD
Epirubicin—Urticaria—Methylprednisolone—asthma	1.51e-05	7.99e-05	CcSEcCtD
Epirubicin—Body temperature increased—Triamcinolone—asthma	1.51e-05	7.97e-05	CcSEcCtD
Epirubicin—Anaphylactic shock—Prednisone—asthma	1.51e-05	7.97e-05	CcSEcCtD
Epirubicin—Oedema—Prednisone—asthma	1.51e-05	7.97e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—CYBA—asthma	1.51e-05	0.000251	CbGpPWpGaD
Epirubicin—Abdominal pain—Methylprednisolone—asthma	1.51e-05	7.96e-05	CcSEcCtD
Epirubicin—Decreased appetite—Dexamethasone—asthma	1.51e-05	7.96e-05	CcSEcCtD
Epirubicin—Decreased appetite—Betamethasone—asthma	1.51e-05	7.96e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—NQO1—asthma	1.51e-05	0.00025	CbGpPWpGaD
Epirubicin—Infection—Prednisone—asthma	1.5e-05	7.92e-05	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Betamethasone—asthma	1.5e-05	7.9e-05	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Dexamethasone—asthma	1.5e-05	7.9e-05	CcSEcCtD
Epirubicin—Hypersensitivity—Hydrocortisone—asthma	1.5e-05	7.89e-05	CcSEcCtD
Epirubicin—Fatigue—Betamethasone—asthma	1.5e-05	7.89e-05	CcSEcCtD
Epirubicin—Fatigue—Dexamethasone—asthma	1.5e-05	7.89e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—ALDH2—asthma	1.49e-05	0.000248	CbGpPWpGaD
Epirubicin—Shock—Prednisone—asthma	1.49e-05	7.84e-05	CcSEcCtD
Epirubicin—Pain—Dexamethasone—asthma	1.48e-05	7.83e-05	CcSEcCtD
Epirubicin—Pain—Betamethasone—asthma	1.48e-05	7.83e-05	CcSEcCtD
Epirubicin—Nervous system disorder—Prednisone—asthma	1.48e-05	7.82e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—PARP1—asthma	1.48e-05	0.000246	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NQO1—asthma	1.48e-05	0.000246	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PPP2CA—asthma	1.48e-05	0.000245	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ADCY2—asthma	1.47e-05	0.000245	CbGpPWpGaD
Epirubicin—Tachycardia—Prednisone—asthma	1.47e-05	7.78e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—AGTR2—asthma	1.47e-05	0.000244	CbGpPWpGaD
Epirubicin—Skin disorder—Prednisone—asthma	1.47e-05	7.74e-05	CcSEcCtD
Epirubicin—Hyperhidrosis—Prednisone—asthma	1.46e-05	7.7e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—IL2—asthma	1.46e-05	0.000243	CbGpPWpGaD
Epirubicin—Asthenia—Hydrocortisone—asthma	1.46e-05	7.68e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CCR5—asthma	1.45e-05	0.000241	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ADCY2—asthma	1.45e-05	0.00024	CbGpPWpGaD
Epirubicin—Anorexia—Prednisone—asthma	1.44e-05	7.6e-05	CcSEcCtD
Epirubicin—Pruritus—Hydrocortisone—asthma	1.44e-05	7.58e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—asthma	1.44e-05	0.000239	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.43e-05	0.000238	CbGpPWpGaD
Epirubicin—Feeling abnormal—Dexamethasone—asthma	1.43e-05	7.54e-05	CcSEcCtD
Epirubicin—Feeling abnormal—Betamethasone—asthma	1.43e-05	7.54e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2RA—asthma	1.43e-05	0.000238	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTT1—asthma	1.42e-05	0.000236	CbGpPWpGaD
Epirubicin—Gastrointestinal pain—Dexamethasone—asthma	1.42e-05	7.48e-05	CcSEcCtD
Epirubicin—Gastrointestinal pain—Betamethasone—asthma	1.42e-05	7.48e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—C3—asthma	1.42e-05	0.000236	CbGpPWpGaD
Epirubicin—Hypersensitivity—Triamcinolone—asthma	1.41e-05	7.43e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—EDNRB—asthma	1.41e-05	0.000234	CbGpPWpGaD
Epirubicin—Hypersensitivity—Methylprednisolone—asthma	1.4e-05	7.41e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—TAC1—asthma	1.39e-05	0.000232	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NPS—asthma	1.39e-05	0.000232	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS1—asthma	1.39e-05	0.000231	CbGpPWpGaD
Epirubicin—Diarrhoea—Hydrocortisone—asthma	1.39e-05	7.33e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—ADCY2—asthma	1.38e-05	0.000229	CbGpPWpGaD
Epirubicin—Urticaria—Dexamethasone—asthma	1.38e-05	7.27e-05	CcSEcCtD
Epirubicin—Urticaria—Betamethasone—asthma	1.38e-05	7.27e-05	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Prednisone—asthma	1.38e-05	7.26e-05	CcSEcCtD
Epirubicin—Dizziness—Prednisolone—asthma	1.37e-05	7.25e-05	CcSEcCtD
Epirubicin—Asthenia—Triamcinolone—asthma	1.37e-05	7.24e-05	CcSEcCtD
Epirubicin—Abdominal pain—Dexamethasone—asthma	1.37e-05	7.23e-05	CcSEcCtD
Epirubicin—Body temperature increased—Dexamethasone—asthma	1.37e-05	7.23e-05	CcSEcCtD
Epirubicin—Abdominal pain—Betamethasone—asthma	1.37e-05	7.23e-05	CcSEcCtD
Epirubicin—Body temperature increased—Betamethasone—asthma	1.37e-05	7.23e-05	CcSEcCtD
Epirubicin—Asthenia—Methylprednisolone—asthma	1.37e-05	7.22e-05	CcSEcCtD
Epirubicin—Insomnia—Prednisone—asthma	1.37e-05	7.21e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CXCR3—asthma	1.37e-05	0.000227	CbGpPWpGaD
Epirubicin—Paraesthesia—Prednisone—asthma	1.36e-05	7.16e-05	CcSEcCtD
Epirubicin—Pruritus—Triamcinolone—asthma	1.35e-05	7.14e-05	CcSEcCtD
Epirubicin—Pruritus—Methylprednisolone—asthma	1.35e-05	7.12e-05	CcSEcCtD
Epirubicin—Dizziness—Hydrocortisone—asthma	1.34e-05	7.08e-05	CcSEcCtD
Epirubicin—Dyspepsia—Prednisone—asthma	1.33e-05	7.02e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CYBA—asthma	1.32e-05	0.00022	CbGpPWpGaD
Epirubicin—TOP2A—Levonorgestrel—Hydrocortisone—asthma	1.32e-05	0.0041	CbGdCrCtD
Epirubicin—Decreased appetite—Prednisone—asthma	1.31e-05	6.93e-05	CcSEcCtD
Epirubicin—Rash—Prednisolone—asthma	1.31e-05	6.92e-05	CcSEcCtD
Epirubicin—Dermatitis—Prednisolone—asthma	1.31e-05	6.91e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—asthma	1.31e-05	0.000218	CbGpPWpGaD
Epirubicin—Diarrhoea—Methylprednisolone—asthma	1.3e-05	6.89e-05	CcSEcCtD
Epirubicin—Fatigue—Prednisone—asthma	1.3e-05	6.87e-05	CcSEcCtD
Epirubicin—Headache—Prednisolone—asthma	1.3e-05	6.87e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—IL5—asthma	1.29e-05	0.000215	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PARP1—asthma	1.29e-05	0.000215	CbGpPWpGaD
Epirubicin—Constipation—Prednisone—asthma	1.29e-05	6.82e-05	CcSEcCtD
Epirubicin—Vomiting—Hydrocortisone—asthma	1.29e-05	6.81e-05	CcSEcCtD
Epirubicin—Rash—Hydrocortisone—asthma	1.28e-05	6.75e-05	CcSEcCtD
Epirubicin—Dermatitis—Hydrocortisone—asthma	1.28e-05	6.75e-05	CcSEcCtD
Epirubicin—Headache—Hydrocortisone—asthma	1.27e-05	6.71e-05	CcSEcCtD
Epirubicin—Dizziness—Triamcinolone—asthma	1.26e-05	6.67e-05	CcSEcCtD
Epirubicin—Dizziness—Methylprednisolone—asthma	1.26e-05	6.65e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—GSTP1—asthma	1.26e-05	0.000209	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—asthma	1.25e-05	0.000208	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—BDKRB2—asthma	1.25e-05	0.000208	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ALB—asthma	1.24e-05	0.000207	CbGpPWpGaD
Epirubicin—Feeling abnormal—Prednisone—asthma	1.24e-05	6.57e-05	CcSEcCtD
Epirubicin—Asthenia—Betamethasone—asthma	1.24e-05	6.57e-05	CcSEcCtD
Epirubicin—Asthenia—Dexamethasone—asthma	1.24e-05	6.57e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—VEGFA—asthma	1.24e-05	0.000206	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—HMOX1—asthma	1.24e-05	0.000206	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ITPR1—asthma	1.24e-05	0.000206	CbGpPWpGaD
Epirubicin—Gastrointestinal pain—Prednisone—asthma	1.23e-05	6.52e-05	CcSEcCtD
Epirubicin—Nausea—Prednisolone—asthma	1.23e-05	6.51e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—GSTP1—asthma	1.23e-05	0.000205	CbGpPWpGaD
Epirubicin—Pruritus—Dexamethasone—asthma	1.23e-05	6.47e-05	CcSEcCtD
Epirubicin—Pruritus—Betamethasone—asthma	1.23e-05	6.47e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—CAT—asthma	1.22e-05	0.000203	CbGpPWpGaD
Epirubicin—Vomiting—Triamcinolone—asthma	1.22e-05	6.41e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—HMOX1—asthma	1.21e-05	0.000202	CbGpPWpGaD
Epirubicin—Vomiting—Methylprednisolone—asthma	1.21e-05	6.4e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—ITPR1—asthma	1.21e-05	0.000202	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADCY2—asthma	1.21e-05	0.000201	CbGpPWpGaD
Epirubicin—Nausea—Hydrocortisone—asthma	1.21e-05	6.36e-05	CcSEcCtD
Epirubicin—Rash—Triamcinolone—asthma	1.21e-05	6.36e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—IL3—asthma	1.2e-05	0.0002	CbGpPWpGaD
Epirubicin—Dermatitis—Triamcinolone—asthma	1.2e-05	6.35e-05	CcSEcCtD
Epirubicin—Rash—Methylprednisolone—asthma	1.2e-05	6.34e-05	CcSEcCtD
Epirubicin—Dermatitis—Methylprednisolone—asthma	1.2e-05	6.34e-05	CcSEcCtD
Epirubicin—Urticaria—Prednisone—asthma	1.2e-05	6.33e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—CAT—asthma	1.2e-05	0.000199	CbGpPWpGaD
Epirubicin—Headache—Triamcinolone—asthma	1.2e-05	6.32e-05	CcSEcCtD
Epirubicin—Headache—Methylprednisolone—asthma	1.19e-05	6.3e-05	CcSEcCtD
Epirubicin—Body temperature increased—Prednisone—asthma	1.19e-05	6.3e-05	CcSEcCtD
Epirubicin—Abdominal pain—Prednisone—asthma	1.19e-05	6.3e-05	CcSEcCtD
Epirubicin—Diarrhoea—Dexamethasone—asthma	1.19e-05	6.26e-05	CcSEcCtD
Epirubicin—Diarrhoea—Betamethasone—asthma	1.19e-05	6.26e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—NQO1—asthma	1.18e-05	0.000196	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ITPR1—asthma	1.16e-05	0.000192	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ADCY2—asthma	1.15e-05	0.000192	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PLA2G4A—asthma	1.15e-05	0.000192	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTM1—asthma	1.15e-05	0.000192	CbGpPWpGaD
Epirubicin—Dizziness—Betamethasone—asthma	1.15e-05	6.05e-05	CcSEcCtD
Epirubicin—Dizziness—Dexamethasone—asthma	1.15e-05	6.05e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.15e-05	0.00019	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TGFB1—asthma	1.14e-05	0.000189	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KNG1—asthma	1.14e-05	0.000189	CbGpPWpGaD
Epirubicin—Nausea—Triamcinolone—asthma	1.14e-05	5.99e-05	CcSEcCtD
Epirubicin—Nausea—Methylprednisolone—asthma	1.13e-05	5.98e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—POMC—asthma	1.13e-05	0.000188	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTM1—asthma	1.13e-05	0.000188	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AGTR1—asthma	1.13e-05	0.000188	CbGpPWpGaD
Epirubicin—Hypersensitivity—Prednisone—asthma	1.11e-05	5.87e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL2—asthma	1.11e-05	0.000184	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6R—asthma	1.1e-05	0.000184	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL10—asthma	1.1e-05	0.000184	CbGpPWpGaD
Epirubicin—Vomiting—Betamethasone—asthma	1.1e-05	5.82e-05	CcSEcCtD
Epirubicin—Vomiting—Dexamethasone—asthma	1.1e-05	5.82e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—CD86—asthma	1.1e-05	0.000183	CbGpPWpGaD
Epirubicin—Rash—Dexamethasone—asthma	1.09e-05	5.77e-05	CcSEcCtD
Epirubicin—Rash—Betamethasone—asthma	1.09e-05	5.77e-05	CcSEcCtD
Epirubicin—Dermatitis—Betamethasone—asthma	1.09e-05	5.76e-05	CcSEcCtD
Epirubicin—Dermatitis—Dexamethasone—asthma	1.09e-05	5.76e-05	CcSEcCtD
Epirubicin—Headache—Dexamethasone—asthma	1.09e-05	5.73e-05	CcSEcCtD
Epirubicin—Headache—Betamethasone—asthma	1.09e-05	5.73e-05	CcSEcCtD
Epirubicin—Asthenia—Prednisone—asthma	1.08e-05	5.72e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—NTRK1—asthma	1.08e-05	0.00018	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADRB2—asthma	1.07e-05	0.000178	CbGpPWpGaD
Epirubicin—Pruritus—Prednisone—asthma	1.07e-05	5.64e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—PPP2CA—asthma	1.06e-05	0.000177	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPP2CA—asthma	1.04e-05	0.000173	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SMAD3—asthma	1.04e-05	0.000173	CbGpPWpGaD
Epirubicin—Diarrhoea—Prednisone—asthma	1.03e-05	5.45e-05	CcSEcCtD
Epirubicin—Nausea—Dexamethasone—asthma	1.03e-05	5.44e-05	CcSEcCtD
Epirubicin—Nausea—Betamethasone—asthma	1.03e-05	5.44e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—ITPR1—asthma	1.01e-05	0.000169	CbGpPWpGaD
Epirubicin—Dizziness—Prednisone—asthma	9.99e-06	5.27e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—asthma	9.99e-06	0.000166	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—RHOA—asthma	9.98e-06	0.000166	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PPP2CA—asthma	9.95e-06	0.000165	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTP1—asthma	9.84e-06	0.000164	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CCR5—asthma	9.77e-06	0.000162	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HMOX1—asthma	9.71e-06	0.000161	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ITPR1—asthma	9.69e-06	0.000161	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CD86—asthma	9.65e-06	0.000161	CbGpPWpGaD
Epirubicin—Vomiting—Prednisone—asthma	9.6e-06	5.07e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—CAT—asthma	9.58e-06	0.000159	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EDN1—asthma	9.58e-06	0.000159	CbGpPWpGaD
Epirubicin—Rash—Prednisone—asthma	9.52e-06	5.02e-05	CcSEcCtD
Epirubicin—Dermatitis—Prednisone—asthma	9.51e-06	5.02e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CCL5—asthma	9.5e-06	0.000158	CbGpPWpGaD
Epirubicin—Headache—Prednisone—asthma	9.46e-06	4.99e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CSF2—asthma	9.36e-06	0.000156	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PDGFB—asthma	9.29e-06	0.000155	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SMAD3—asthma	9.11e-06	0.000152	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PLA2G4A—asthma	9.05e-06	0.00015	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTM1—asthma	9.05e-06	0.00015	CbGpPWpGaD
Epirubicin—Nausea—Prednisone—asthma	8.97e-06	4.73e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL8—asthma	8.76e-06	0.000146	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PPP2CA—asthma	8.72e-06	0.000145	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR5—asthma	8.56e-06	0.000142	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL2RA—asthma	8.44e-06	0.00014	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2—asthma	8.37e-06	0.000139	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—C3—asthma	8.37e-06	0.000139	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPP2CA—asthma	8.33e-06	0.000139	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS2—asthma	8.28e-06	0.000138	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—POMC—asthma	8.16e-06	0.000136	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PDGFB—asthma	8.14e-06	0.000135	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—POMC—asthma	8e-06	0.000133	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LEP—asthma	7.79e-06	0.00013	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6R—asthma	7.45e-06	0.000124	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALB—asthma	7.44e-06	0.000124	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FN1—asthma	7.34e-06	0.000122	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALB—asthma	7.3e-06	0.000121	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NOS3—asthma	7.12e-06	0.000118	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NOS3—asthma	6.98e-06	0.000116	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SERPINE1—asthma	6.97e-06	0.000116	CbGpPWpGaD
Epirubicin—ABCC1—Disease—RHOA—asthma	6.73e-06	0.000112	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—POMC—asthma	6.69e-06	0.000111	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS3—asthma	6.66e-06	0.000111	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL2—asthma	6.55e-06	0.000109	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6R—asthma	6.53e-06	0.000109	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—asthma	6.51e-06	0.000108	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EGFR—asthma	6.4e-06	0.000106	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—POMC—asthma	6.39e-06	0.000106	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—asthma	6.38e-06	0.000106	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD4—asthma	6.13e-06	0.000102	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SERPINE1—asthma	6.11e-06	0.000102	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—asthma	6.09e-06	0.000101	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RHOA—asthma	5.9e-06	9.8e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOS3—asthma	5.83e-06	9.7e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALB—asthma	5.83e-06	9.69e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTEN—asthma	5.68e-06	9.44e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NOS3—asthma	5.58e-06	9.27e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTEN—asthma	5.57e-06	9.26e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTEN—asthma	5.31e-06	8.83e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL8—asthma	5.18e-06	8.61e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—asthma	5.1e-06	8.48e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL2—asthma	4.95e-06	8.23e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6—asthma	4.92e-06	8.18e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—STAT3—asthma	4.75e-06	7.9e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP9—asthma	4.68e-06	7.78e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTEN—asthma	4.65e-06	7.74e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTEN—asthma	4.45e-06	7.4e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TGFB1—asthma	4.4e-06	7.32e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—EGFR—asthma	4.32e-06	7.18e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VEGFA—asthma	4.2e-06	6.99e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—STAT3—asthma	4.16e-06	6.92e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TGFB1—asthma	3.86e-06	6.42e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EGFR—asthma	3.78e-06	6.29e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6—asthma	3.32e-06	5.52e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6—asthma	2.91e-06	4.83e-05	CbGpPWpGaD
